SURMOUNT-2: Tirzepatide achieved up to 15.7% weight lossSeventy-two week outcomes from the SURMOUNT-2 trial has revealed that tirzepatide (10mg and 15mg) achieved superior weight loss compared...
Standardisation of OAGB is key to reducing surgical errors and ensuring consistent patient outcomes6 hours ago